Literature DB >> 24527979

Target gene abundance contributes to the efficiency of siRNA-mediated gene silencing.

Sun Woo Hong1, Yuanyuan Jiang, Soyoun Kim, Chiang J Li, Dong-ki Lee.   

Abstract

The gene-silencing activity of a small interfering RNA (siRNA) is determined by various factors. Considering that RNA interference (RNAi) is an unparalleled technology in both basic research and therapeutic applications, thorough understanding of the factors determining RNAi activity is critical. This report presents observations that siRNAs targeting KRT7 show cell-line-dependent activity, which correlates with the expression level of KRT7 mRNA. By modulating the target mRNA level, it was confirmed that highly expressed genes are more susceptible to siRNA-mediated gene silencing. Finally, several genes that show different expression levels in a cell-line dependent manner were tested, which verified the expression-level-dependent siRNA activities. These results strongly suggest that the abundance of target mRNA is a critical factor that determines the efficiency of the siRNA-mediated gene silencing in a given cellular context. This report should provide practical guidelines for designing RNAi experiments and for selecting targetable genes in RNAi therapeutics studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24527979      PMCID: PMC4026300          DOI: 10.1089/nat.2013.0466

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN: 2159-3337            Impact factor:   5.486


  29 in total

1.  Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference.

Authors:  Kumiko Ui-Tei; Yuki Naito; Fumitaka Takahashi; Takeshi Haraguchi; Hiroko Ohki-Hamazaki; Aya Juni; Ryu Ueda; Kaoru Saigo
Journal:  Nucleic Acids Res       Date:  2004-02-09       Impact factor: 16.971

2.  The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides.

Authors:  Rosel Kretschmer-Kazemi Far; Georg Sczakiel
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

3.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

Review 4.  siRNAs: applications in functional genomics and potential as therapeutics.

Authors:  Yair Dorsett; Thomas Tuschl
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

5.  Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor.

Authors:  Torgeir Holen; Mohammed Amarzguioui; Merete T Wiiger; Eshrat Babaie; Hans Prydz
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

6.  The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript.

Authors:  Erin A Bohula; Amanda J Salisbury; Muhammad Sohail; Martin P Playford; Johann Riedemann; Edwin M Southern; Valentine M Macaulay
Journal:  J Biol Chem       Date:  2003-02-24       Impact factor: 5.157

7.  Analysis of gene function in somatic mammalian cells using small interfering RNAs.

Authors:  Sayda M Elbashir; Jens Harborth; Klaus Weber; Thomas Tuschl
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

8.  ENCODE whole-genome data in the UCSC Genome Browser: update 2012.

Authors:  Kate R Rosenbloom; Timothy R Dreszer; Jeffrey C Long; Venkat S Malladi; Cricket A Sloan; Brian J Raney; Melissa S Cline; Donna Karolchik; Galt P Barber; Hiram Clawson; Mark Diekhans; Pauline A Fujita; Mary Goldman; Robert C Gravell; Rachel A Harte; Angie S Hinrichs; Vanessa M Kirkup; Robert M Kuhn; Katrina Learned; Morgan Maddren; Laurence R Meyer; Andy Pohl; Brooke Rhead; Matthew C Wong; Ann S Zweig; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2011-11-09       Impact factor: 16.971

9.  Integrated siRNA design based on surveying of features associated with high RNAi effectiveness.

Authors:  Wuming Gong; Yongliang Ren; Qiqi Xu; Yejun Wang; Dong Lin; Haiyan Zhou; Tongbin Li
Journal:  BMC Bioinformatics       Date:  2006-11-27       Impact factor: 3.169

10.  HuSiDa--the human siRNA database: an open-access database for published functional siRNA sequences and technical details of efficient transfer into recipient cells.

Authors:  Matthias Truss; Maciej Swat; Szymon M Kielbasa; Reinhold Schäfer; Hanspeter Herzel; Christian Hagemeier
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

View more
  15 in total

1.  Optimization of double-stranded RNAi intrathoracic injection method in Aedes aegypti.

Authors:  Seokyoung Kang; Dongyoung Shin; Mi Young Noh; Jill S Peters; Chelsea T Smartt; Yeon Soo Han; Young S Hong
Journal:  Entomol Res       Date:  2018-07-12       Impact factor: 1.306

2.  Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.

Authors:  Diana Alarcón-Arís; Ariadna Recasens; Mireia Galofré; Iria Carballo-Carbajal; Nicolás Zacchi; Esther Ruiz-Bronchal; Rubén Pavia-Collado; Rosario Chica; Albert Ferrés-Coy; Marina Santos; Raquel Revilla; Andrés Montefeltro; Isabel Fariñas; Francesc Artigas; Miquel Vila; Analia Bortolozzi
Journal:  Mol Ther       Date:  2017-11-29       Impact factor: 11.454

3.  GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.

Authors:  S Yuan; Z Yu; Q Liu; M Zhang; Y Xiang; N Wu; L Wu; Z Hu; B Xu; T Cai; X Ma; Y Zhang; C Liao; L Wang; P Yang; L Bai; Y Li
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

4.  Identification of endoplasmic-reticulum-associated proteins involved in Bombyx mori nucleopolyhedrovirus entry by RNA-seq analysis.

Authors:  Bifang Hao; Chenya Li; Charles Amanze; Jinshan Huang
Journal:  Arch Virol       Date:  2022-02-24       Impact factor: 2.574

5.  Chorionic somatomammotropin RNA interference alters fetal liver glucose utilization.

Authors:  Asghar Ali; Callie M Swanepoel; Quinton A Winger; Paul J Rozance; Russell V Anthony
Journal:  J Endocrinol       Date:  2020-12       Impact factor: 4.286

6.  Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing.

Authors:  Karine Cambon; Virginie Zimmer; Sylvain Martineau; Marie-Claude Gaillard; Margot Jarrige; Aurore Bugi; Jana Miniarikova; Maria Rey; Raymonde Hassig; Noelle Dufour; Gwenaelle Auregan; Philippe Hantraye; Anselme L Perrier; Nicole Déglon
Journal:  Mol Ther Methods Clin Dev       Date:  2017-05-11       Impact factor: 6.698

7.  Identification of highly effective target genes for RNAi-mediated control of emerald ash borer, Agrilus planipennis.

Authors:  Thais B Rodrigues; Jian J Duan; Subba R Palli; Lynne K Rieske
Journal:  Sci Rep       Date:  2018-03-22       Impact factor: 4.379

8.  RNA interference and validation of reference genes for gene expression analyses using qPCR in southern pine beetle, Dendroctonus frontalis.

Authors:  Bethany R Kyre; Thais B Rodrigues; Lynne K Rieske
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

9.  Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).

Authors:  Mahsa Mohseni; Cezary Kucharski; Remant Bahadur K C; Mohammad Nasrullah; Xiaoyan Jiang; Hasan Uludağ; Joseph Brandwein
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

10.  Identification and application of exogenous dsRNA confers plant protection against Sclerotinia sclerotiorum and Botrytis cinerea.

Authors:  Austein G McLoughlin; Nick Wytinck; Philip L Walker; Ian J Girard; Khalid Y Rashid; Teresa de Kievit; W G Dilantha Fernando; Steve Whyard; Mark F Belmonte
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.